Prescription drug · NDA
Zirgan (Ganciclovir) NDC 24208-535
Ganciclovir 1.5 mg/g · Gel · Ophthalmic · Bausch & Lomb Incorporated
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 24208-535-15 | 2420805351524208053515 | 1 TUBE, WITH APPLICATOR in 1 CARTON (24208-535-15) / 1.5 g in 1 TUBE, WITH APPLICATORMarketed from Apr 30, 2010 | |
| 24208-535-35 | 2420805353524208053535 | 1 TUBE, WITH APPLICATOR in 1 CARTON (24208-535-35) / 5 g in 1 TUBE, WITH APPLICATORMarketed from Apr 30, 2010 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Zirgan
- Generic name (nonproprietary)
- ganciclovir
- Active ingredients
- Ganciclovir — 1.5 mg/g
- Dosage form
- Gel
- Route
- Ophthalmic
- Labeler
- Bausch & Lomb IncorporatedNDC labeler code 24208
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 022211
- Marketing start
- Listing expires
- Other FDA classes
- DNA Polymerase Inhibitors (Mechanism)Nucleoside Analog (EXT)
- Identifiers
- Product ID 24208-535_52207853-4445-f142-e063-6394a90a281cSPL ID 52207853-4445-f142-e063-6394a90a281cSPL set ID ea25e7ac-7a93-4ec8-975b-2cec197e1c27RxCUI 388052, 864650UNII P9G3CKZ4P5
- Pharmacologic class
- Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor; Nucleoside Analog Antiviral
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N424208053515followed by a unit qualifier and the quantityPackage 24208-0535-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
ZIRGAN is indicated for the treatment of acute herpetic keratitis (dendritic ulcers) in adults and pediatric patients aged 2 years and older. ZIRGAN is a nucleoside analog antiviral indicated for the treatment of acute herpetic keratitis (dendritic ulcers) in adults and pediatric patients aged 2 years and older. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 24208-535
- What is NDC 24208-535?
- 24208-535 is the product NDC for Zirgan (ganciclovir), Ganciclovir 1.5 mg/g gel, listed with the FDA by Bausch & Lomb Incorporated. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Zirgan (Ganciclovir).
- What is the active ingredient?
- Ganciclovir.
- Who is the labeler?
- Bausch & Lomb Incorporated, NDC labeler code 24208. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Zirgan?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.